Drawing for PHARMAGENE

USPTO serial 75207048

PHARMAGENE

Reviewed by CopyMark Law Group

Reg. 2231360Status 710
Filing date
Status date
Registration date
Mar 16, 1999
Examiner
BENMAMAN, ALICE
Law office
POST REGISTRATION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with PHARMAGENE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
009computer software, magnetic discs, and optical discs containing pre-recorded databases and other information in the field of geneticsSECTION 8 - CANCELLED—
016books, reports, manuals, copies of research documents, in the field of geneticsSECTION 8 - CANCELLED—
039electronic storage of genetic informationSECTION 8 - CANCELLED—
041library services in the field of geneticsSECTION 8 - CANCELLED—
042consulting in the field of genetics, especially as to gene form and gene function; laboratory research in the field of genetics; pharmacology testing and assay services; design and development of pharmaceutical products for others; technical consultation and research in the genetics and pharmacological fieldsSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 17, 2009CAEXCANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9—
Apr 29, 2005C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Mar 15, 2005815FREGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED—
Mar 15, 2005E815TEAS SECTION 8 & 15 RECEIVED—
Jan 30, 2003MAILPAPER RECEIVED—
Jan 22, 2003TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 16, 1999R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 25, 1999IUCNNOTICE OF ALLOWANCE CANCELLED—
Dec 29, 19981.BDSec. 1(B) CLAIM DELETED—
Jul 28, 1998NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
May 5, 1998PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 3, 1998NPUBNOTICE OF PUBLICATION—
Feb 12, 1998CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 14, 1998CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 14, 1997CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 27, 1997DOCKASSIGNED TO EXAMINER—
Jun 23, 1997DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance